(Reuters) – U.S. state of Nevada’s recent ban on the use of Quidel Corp’s Sofia and Becton Dickinson and Co’s (BD) Veritor point of care antigen tests in long-term care facilities violates federal law, a U.S. government official said on Friday.
“The letter (on ban) from Nevada officials can only be interpreted as reflecting a fundamental lack of basic knowledge about testing and interpreting results,” said Admiral Brett Giroir, assistant secretary for health at the U.S. Department of Health and Human Services, in a press briefing.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Shinjini Ganguli)
